<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03310307</url>
  </required_header>
  <id_info>
    <org_study_id>Hcy-VitD-01</org_study_id>
    <nct_id>NCT03310307</nct_id>
  </id_info>
  <brief_title>Vitamin D3 Treatment and Homocysteine Concentrations Among Overweight Reproductive Women</brief_title>
  <official_title>Vitamin D3 Treatment Decreases Serum Total Homocysteine Concentrations of Overweight Reproductive Women: Randomized Placebo Controlled Clinical Trail</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Al-Balqa Applied University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jordan University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Al-Balqa Applied University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      100 overweight reproductive vitamin D deficient women were divided into two groups; vitamin D
      (n = 50) and placebo (n = 50). Vitamin D group received treatment dose of 50,000 IU of
      vitamin D3 per week for 2 consecutive months and placebo group received placebo tablets
      similar in size, shape and color to vitamin D3 for 2 months also. Total homocysteine
      concentrations were measured before intervention (basal), on 30 days (one month) and on 60
      days (2 months) of intervention. Changes in means of homocysteine concentrations for placebo
      and vitamin D group over time showed significant difference on 30 and 60 days of
      intervention. Mean comparisons of homocysteine concentrations and standard error of the means
      before and after intervention showed statistical significant decrease in homocysteine
      concentrations among vitamin D group.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2016</start_date>
  <completion_date type="Actual">October 30, 2016</completion_date>
  <primary_completion_date type="Actual">August 30, 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking_description>Double blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>25(OH)D3</measure>
    <time_frame>2 months</time_frame>
    <description>vitamin D in serum</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Homocysteine</measure>
    <time_frame>2 months</time_frame>
    <description>serum total homocysteine</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Homocystinaemia</condition>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>vitamin D3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>50,000 IU</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Similar in size, shape and color to vitamin D3</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vit D</intervention_name>
    <description>50,000 IU</description>
    <arm_group_label>vitamin D3</arm_group_label>
    <other_name>Biodal</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Overweight (BMI between 25-29.99 kg/m2)

          -  Had 25(OH)D &lt; 20 ng/mL

          -  Had normal vitamin B-12 and folic acid levels

          -  Not diagnosed with any chronic diseases

          -  Agreed to participat in the study

        Exclusion Criteria:

          -  age &lt; 18 or &gt; 49 years

          -  BMI &gt; 30 kg/m2 or &lt; 25 kg/m2

          -  25 (OH)D level &gt; 20 ng/ml

          -  tHcy levels greater than 100 Âµmol/L

          -  Abnormal vitamin B-12 or folic acid levels

          -  Chronic diseases

          -  Pregnant or lactating
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Attending obstetric and gynecology clinics at King Abdullah University Hospital</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jehan M Hamadneh, FRCOG</last_name>
    <role>Principal Investigator</role>
    <affiliation>JUST</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nahla S Al-Bayyari, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>BAU</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>King Abdullah University Hospital</name>
      <address>
        <city>Irbid</city>
        <country>Jordan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Jordan</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2017</study_first_submitted>
  <study_first_submitted_qc>October 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 16, 2017</study_first_posted>
  <last_update_submitted>October 13, 2017</last_update_submitted>
  <last_update_submitted_qc>October 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Al-Balqa Applied University</investigator_affiliation>
    <investigator_full_name>Nahla Bayyari</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Homocysteine</keyword>
  <keyword>Overweight</keyword>
  <keyword>vitamin D3</keyword>
  <keyword>Reproductive women</keyword>
  <keyword>RCT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

